In this Issue:
Bleeding risk with aspirin for primary CV disease prevention
Ruxolitinib vs. best available therapy for polycythaemia vera
Azacitidine for post-transplant relapse in AML
Effectiveness and safety of DOACs vs. warfarin in AF
Relapse risk in Hodgkin’s lymphoma at EFS timepoints and survival
DASISION trial final results
Everolimus with R-CHOP-21 for untreated DBLCL
Retroviral gene therapy in adenosine deaminase deficiency
Maintenance rituximab in CML after response to rituximab regimen
Please login below to download this issue (PDF)